Page 386 - Industrial Ventilation Design Guidebook
P. 386

REFERENCES                                                               34 I

                117. Clancy, R. M., and Abramson, S. B. (1993). Nitric oxide: A novel mediaror of inflammation,
                    Proc. Soc. Exp, Biol. Med. 210, 93-101.
                118. Hibbs, J. B., Taintor, R. R., Vavrin, Z., and Rachlin, E. M. (1988). Nitric oxide: A cytotoxic
                    activated macrophage effector molecule. Biochem. Biopbys. Res. Commnn. 157, 87-94.
                119. Laskin, J. D., Heck, D. E., and Laskin, D. L. (1994.) Multifunctional role of nitric oxide in
                    inflammation. TEM 5, 377-382.
                120. Burns, L. A., Meade, B. J,, and Munson, A. E. (1996). Toxic responses of tht immune s\stxnt.
                    In Casarett and Doull's Toxicology: The Basic Science of Poisons (C. D. klaassen t d . pp.
                    355-402. McGraw-Hill, New York.
                121. Corcoran, G. B., and Ray, S. D. (1992). The roie of the nucleus and other compartments in toxic
                    cell death produced by alkylating hepatotoxicants. Toxicol. Appl. PharmacoL 113(2), 167-183.
                122. Bursch, W. Oberhammer, E, and Schulte-Hermann, R. (1992). Cell, death by apoptosis and its
                    protective role against disease. Trends PharmacoL Sci. 13(6), 245-251.
                123. Nagata, S., and Goldstein, P., (1995). The Fas death factor. Science 267(5203), 1449-1456,
                124. Dybukt, J. M.., Ankarcrona, M., Burkitt, M., Sjoholm, A., Strom, K., Orrenius, S., and Nico-
                    tera, P. (1994). Different prooxidant levels stimulate growth, trigger apoptosis, or produce
                    necrosis of insulin-secreting RINm5F cells. /. Biol. Chem. 269, 30553-30560.
                125. Dekant, W., and Vamvakas, S. (1996). Biotransformation and membrane transport in nephro-
                    toxicity. Crit. Rev. Toxicol. 26(3): 309-334.
                126.Solberg, Y., and Belkin, M. (1997). The role of excitotoxicity in organophosphorous nerve
                    agents central poisoning. Trends. PharmacoL Set. 18(6), 183-185.
                127. Brown, M. A., and Brix, K. A. (1998). Review of health consequences from high-, intermedi-
                    ate- and low-level exposure to organophosphorus nerve agents./. Appl. Toxicol. 18, 393-408.
                128. HalHwell, B. (1997). Antioxidants: The basics—what they are and how to evaluate them. Adv.
                   PharmacoL 38, 3-20.
                129. van Delft J. H. M., Baan, R. A., and Roza, L. (1998). Biological effect markers for exposure to car-
                   cinogenic compound and their relevance for risk assessment. Crit. Rev. Toxicol. 28(5), 477-510.
                130. Hoffmann, G. R. (1996). Genetic toxicology. In Casarett and Doull's Toxicology: The Basic
                   Science of Poisons (C. D. Klaassen, Ed.), p. 281. McGraw-Hill, New York.
                131. Parkinson, A. (1996). Biotransformation of xenobiotics. In Casarett and Doull's Toxicology:
                    The Basic Science of Poisons (C. D. Klaassen, Ed.), pp. 113-186. McGraw-Hill, New York.
                132. Kraeling, M. E. K., Reddy, K., and Bronaugh, R. L. (1998). Percutaneous absorption of trini-
                   trobenzene: anima! models for human skin. /. Appl. Toxicol. 18, 387-392.
                133. Cavanagh, J. B. (1985). Mechanism of organic solvent toxicity: Morphological changes. WHO
                    Environmental Health Series 5, 110—135.
                134. Mikkelsen, S., Jorgensen, M., Browne, E., and Gyldensten, C. (1988). Mixed solvent exposure
                   and organic brain damage: A study of painters. Acta N euro I. Scand. 78, 1—143.
                135. Atterwill, C. K. (1989). Brain reaggregate cultures in neurotoxicological investigations: Adap-
                   tational and neurodegenerative processes following lesions. Mo/. Toxicol. 1, 489—502.
                136. Spencer, P. S., and Schaumburg, H. H. (1985). Organic solvent neurotoxicity: Facts and
                   research needs. Scand. J. Environ. Health 11, 53-60.
                1.37. Bast, A. (1996). Anatomy and toxicological pathology of the nervous system. In Toxicology:
                   Principles and Applications (R. J. M. Niesink, J. de Vries, J. and M. A. Hollinger, Eds.}, pp.
                    974-1001. CRC Press, Boca Raton, FL.
                138. Ruff, R. L., Petito, C. K., and Acheson, L. S. (1981). Neuropathy associated with chronic low
                   level exposure to w-hexane. din. Toxicol. 18, 515-519.
                139. Bernsen, H. J. J. A., Verhagen, V. I. M., De Bijl, M. A. O., and Heerschap, A. (1992). Magnetic
                    resonance studies on brain dysfunction induced by organic solvents. Acta Neural. Belg. 92,
                   207-214.
                140. Potts, A. M. (1996). Toxic responses of the eye. In Casarett and Doull's Toxicology: The Basic
                   Science of Poisons (C.D. Klaassen, Ed.), pp. 583-615. McGraw-Hill, New York.
                141. Doll, R., Peto, T, Wheatley, K., Gray, R., and Sutherland, I. (1994). Mortality in relation to
                   smoking: 40 years' observations on male British doctors. Brit. Med. J. 309, 901-911.
                142. Doll, R., and Hill, A. B. (1950). Smoking and carcinoma of the lung: Preliminary report. BMJ
                   ii, 739-748
                143. Doll, R., and Hill, A. B, (1964). Mortality in relation to smoking: Ten years' observation of
                   British, doctors. BMJ ii, 1399-1414, 1460-1467.
   381   382   383   384   385   386   387   388   389   390   391